| Any HPV | Oncogenic HPV | Non-Oncogenic HPV |
---|
| | | Univariatea
| Multivariateb
| | | Univariatea
| Multivariatec
| | | Univariatea
| Multivariated
|
---|
Circumcision | Inf./ Total | % | HR (95% CI) | AHR (95% CI) | Inf./ Total | % | HR (95% CI) | AHR (95% CI) | Inf./ Total | % | HR (95% CI) | AHR (95% CI) |
---|
No
| 555/ 1174 | 47.3 | 1.00 | 1.00 | 584/ 1795 | 32.5 | 1.00 | 1.00 | 596/ 1441 | 41.4 | 1.00 | 1.00 |
Yes
| 359/ 745 | 48.2 | 1.08 (0.92 – 1.27) | 1.08 (0.91 – 1.27) | 369/ 1035 | 35.7 | 1.11 (0.94 – 1.31) | 1.11 (0.94 – 1.31) | 372/ 917 | 40.6 | 1.09 (0.93 – 1.28) | 1.11 (0.94 – 1.30) |
Total
| 914/ 1919 | | | | 953/ 2830 | | | | 968/ 2358 | | | |
-
aAdjusted for age and country;
-
bAdjusted for country, age, marital status, lifetime number of female sexual partners, recent number of female sexual partners, recent number of male anal sex partners, and six-month visit compliance status;
-
cAdjusted for country, age, marital status, lifetime number of female sexual partners, recent number of female sexual partners, and recent number of male anal sex partners;
-
dCox model stratified by age and adjusted for country, marital status, lifetime number of female sexual partners, recent number of female sexual partners, lifetime number of male anal sex partners, and six-month visit compliance status;
- NOTE: Unit of analysis: men; Inf., infections; HR, hazard ratio; CI, confidence interval; AHR, adjusted hazard ratio.